A detailed history of Twin Focus Capital Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Twin Focus Capital Partners, LLC holds 618 shares of LLY stock, worth $555,025. This represents 0.09% of its overall portfolio holdings.

Number of Shares
618
Previous 634 2.52%
Holding current value
$555,025
Previous $369,000 30.08%
% of portfolio
0.09%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $9,475 - $12,676
-16 Reduced 2.52%
618 $480,000
Q4 2023

Mar 05, 2024

SELL
$525.19 - $619.13 $89,282 - $105,252
-170 Reduced 21.14%
634 $369,000
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $47,267 - $55,721
90 Added 12.61%
804 $468,000
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $260,385 - $358,980
-599 Reduced 45.62%
714 $383,000
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $43,141 - $57,684
123 Added 10.34%
1,313 $615,000
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $4,501 - $5,245
-14 Reduced 1.16%
1,190 $435,000
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $39,431 - $44,936
-133 Reduced 9.95%
1,204 $389,000
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $38,186 - $44,835
-137 Reduced 9.29%
1,337 $433,000
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $11,265 - $13,999
-48 Reduced 3.15%
1,474 $422,000
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $17,313 - $21,486
77 Added 5.33%
1,522 $420,000
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $3,324 - $4,090
-15 Reduced 1.03%
1,445 $334,000
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $63,192 - $81,739
350 Added 31.53%
1,460 $335,000
Q1 2021

May 12, 2021

SELL
$164.32 - $212.72 $13,145 - $17,017
-80 Reduced 6.72%
1,110 $207,000
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $155,247 - $205,429
1,190 New
1,190 $201,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $853B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Twin Focus Capital Partners, LLC Portfolio

Follow Twin Focus Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Focus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Twin Focus Capital Partners, LLC with notifications on news.